- $194.24m
- -$14.48m
- $134.48m
Brief: RxSight Files Shelf Registration Statement, Announces $50 Mln At-The-Market Equity Offering Program
Brief: RxSight Receives FDA Notification That Additional Information Will Be Required For Approval Of Light Delivery Device
Brief: Rxsight Inc Reports First Quarter 2022 Financial Results
Rxsight Inc reports results for the quarter ended in March - Earnings Summary
Rxsight Inc expected to post a loss of 65 cents a share - Earnings Preview
BTIG says favors medical device makers tied to elective procedures
Needham sees promise in RxSight's intraocular lens, starts with 'buy'
U.S. RESEARCH ROUNDUP- Camden Property Trust, Shift4 Payments, Valvoline,
Brief: RxSight Reports Q4 And Fiscal Year 2021 Financial Results
Rxsight Inc reports results for the quarter ended in December - Earnings Summary
Brief: Rxsight, Inc. Appoints Dr. Tamara R. Fountain, M.D. And Shweta Singh Maniar To Its Board Of Directors
Rxsight Inc reports results for the quarter ended in September - Earnings Summary
Brief: RxSight Reports Q3 2021 Financial Results
U.S. RESEARCH ROUNDUP-Aspen Aerogels, Editas Medicine, Humanigen
Brief: Rxsight Reports Q2 Loss Per Share $3.53
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM
Brief: Rxsight Announces Pricing Of Initial Public Offering